CA
TXMD icon

Corrado Advisors’s TherapeuticsMD TXMD Stock Holding History

Corrado Advisors’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-907
Closed -$297K – 102
2018
Q3 		$297K Sell
907
-537
-37% -$165K 0.19% 77
2018
Q2 		$450K Sell
1,444
-80
-5% -$24.4K 0.27% 62
2018
Q1 		$371K Buy
1,524
+441
+41% +$124K 0.22% 73
2017
Q4 		$327K Buy
1,083
+20
+2% +$5.57K 0.19% 77
2017
Q3 		$281K Buy
+1,063
New +$307K 0.16% 88

Other funds holding TXMD

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Corrado Advisors's TXMD Position: Q4 2018 in Review

Corrado Advisors sold out of TherapeuticsMD (TXMD) in Q4 2018, closing a stake of 907 shares — an estimated $297K sold.

Corrado Advisors first reported a position in TXMD in Q3 2017 and held it in 5 quarters. The position peaked at $450K in Q2 2018. 140 funds tracked by Wall St. Rank hold TXMD as of Q4 2018.

  • Corrado Advisors reported no remaining TherapeuticsMD position as of Q4 2018 after selling out during the quarter.
  • Corrado Advisors sold 907 TherapeuticsMD shares in Q4 2018, an estimated $297K.
  • Corrado Advisors first reported a position in TherapeuticsMD in Q3 2017 and held it in 5 quarters.
  • Corrado Advisors's TherapeuticsMD position peaked at $450K in Q2 2018.
  • 140 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2018.

Based on Corrado Advisors's 13F filing for Q4 2018, filed 9 Jan 2019.